Latest news and industry updates from HL Pharma - Specialising in the sourcing, supply and distribution of products unavailable in Australia.
Building on its range of licensed products, HL Pharma is excited announce it now has the exclusive Australian distribution rights for the Carnation® Footcare product range and Carnation® Corn Caps....
The Therapeutic Goods Administration (TGA) has issued 5 infringement notices totalling $13,320 to 3 health practitioners for the alleged unlawful importation of unregistered prescription-only...
HL Pharma is excited to announce Dr Paula Martin has joined the team, partnering on the WomanCare Global obstetric and gynaecological product range.
A US physician, Dr Joan Fleischman believes training doctors in this easy method for miscarriage extraction and abortion, might be the best way to address the health care shortfall in this area of...
From 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA (3,4-methylenedioxy-methamphetamine) can be prescribed by specifically authorised psychiatrists for the...
HL Pharma is the distributor of the ARTG registered product Hope Pharmaceuticals Sodium Thiosulfate Pentahydrate 12.5 g/50 mL solution for Injection Vial (the Product), sponsored by Hope...
Stocks of essential medicines are running short with health care professionals struggling to deal with post-COVID-19 medication shortages. Let HL Pharma assist where we can. Read more
A newly approved eye drop hitting the market on Thursday could change the lives of millions of Americans with age-related blurred near vision, a condition affecting mostly people 40 and older.
